|
Verlieren die ersten institutionellen Anteilseigner ihr Interesse an der geplanten Fusion ??? Certain institutional shareholders not happy with Bristol-Myers-Celgene tie-up Feb. 20, 2019 2:36 PM ET| About: Bristol-Myers Squibb C... (BMY)|By: Douglas W. House, SA News Editor Bristol-Myers Squibb (BMY -0.3%) and Celgene (CELG -0.1%) are both off their intraday highs in the wake of reports that certain institutional shareholders, including Starboard Value and Dodge & Cox, lack enthusiasm for the planned merger. Starboard intends to survey stockholders to gauge their support for the cash-and-stock transaction. Update: The WSJ reports that Starboard has nominated five potential directors, including CEO Jeff Smith, and has been meeting with BMY executives. It only owns ~1M shares of the ~1.6B outstanding so it will have to recruit many more shareholders if it wants to challenge the deal. https://seekingalpha.com/news/3435183-certain-institutional-…" target="_blank" rel="nofollow ugc noopener"> https://seekingalpha.com/news/3435183-certain-institutional-… |
|
| aus der Diskussion: | CELGENE ( CELG) > Biotech-Blue-Chip als LONGzeitinvestment mit großer Zukunftsperspektive !? |
| Autor (Datum des Eintrages): | bernie55 (21.02.19 12:20:45) |
| Beitrag: | 332 von 384 (ID:59930831) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |